Ledger.Open graph →

SEC Form D · filed February 22, 2017

Insilico Medicine, Inc

Offering

$10.0M

Sold

$10.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Aleksandrs Zavoronkovs · London, United KingdomExec · Director Aleksandrs Zavoronkovs · London, United KingdomExec · Director Carey Ng · La Jolla, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗